About
Basic Data Updated:
2 months agoGranules India Limited is known as a medium-sized pharmaceutical company that is involved in the production of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and finished formulations, according to its credit rating report. The company's range of products includes some of the widely used and standardized analgesics such as paracetamol, ibuprofen and naproxen, along with a popular anti-diabetic medication called metformin. Its primary markets are the United States and Europe, where it exports approximately 80% of its total turnover. The company's operations are carried out in three manufacturing facilities located in India, all of which have received approvals from the US FDA, European Authorities, and Australia's TGA.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Granules India Limited
Pharmaceutical Intermediates
Textile Finishing Machine
Financials of Granules India Limited
Granules India Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.04% increase. The company also saw a substantial improvement in profitability, with a 29.05% increase in profit. The company's net worth moved up by a moderate rise of 6.67%.
Enhance accessibility to Granules India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Granules India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Granules India Limited
Unlock and access historical data on people associated with Granules India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
Chigurupati Prasad
Managing DirectorAppointment Date: 31-Aug-1994
Status: Current
KS
Kandiraju Sitaramrao Managing DirectorAppointment Date: 05-Jan-2022
Status: Current
MS
Mukesh Surana CFOStatus: Current
CT
Chaitanya Tummala Company SecretaryStatus: Current
Board Members(10)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Trusteeship Services Limited Creation Date: 11 Jun 2019 | ₹860.00 Cr | Open |
Others Creation Date: 10 Oct 2017 | ₹315.00 Cr | Open |
Others Creation Date: 10 Oct 2017 | ₹140.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Granules India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Granules India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Krsma Vineyards Private Limited
Active
16 years 2 months Chigurupati Prasad and Umadevi Chigurupati are mutual person
Recent activity within the organization
Annual General Meeting
Granules India Limited last Annual general meeting of members was held on 10 Aug 2023 as per latest MCA records.
10 Aug 2023Director Appointment
Kapil Mehan was appointed as a Director was appointed as a Director on 16 May 2023 & has been associated with this company since 11 months 18 days .
16 May 2023Balance Sheet
Granules India Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge registered on 11 Jan 1995 via Charge ID 90131139 with A.P.State Financial Corporation was fully satisfied on 30 Mar 2023.
30 Mar 2023Charges
A charge with Idbi Trusteeship Services Limited of Rs. 860.00 cr registered on 11 Jun 2019 with Charge ID 100271868 was modified on 29 Jul 2022.
29 Jul 2022
Recent News, Updates & Announcement
Granules India Q3 FY24 Results Live profit rise by 106 YOY Mint.Granules India Q3 FY24 Results Live Revenue increased by 083 YoY profit increasedby 106 YoY.
mint 25 Jan 2024
- Granules Indias Revenue From Operation Increases by 8 to INR 393 Crore.
Prnewswire 09 Nov 2017
- Granules India Rises After Vizag Facility Gets EIR From USFDA.
Medicalbuyer 09 Oct 2017
- Granules India trades jubilantly on plan of investing 84 million for expansion.
Finalaya 21 Feb 2017
- Granules India plans to invest 84 million for expansion.
Finalaya 21 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Granules India Limited?
